Brain Metastases in Renal Cell Carcinoma: Immunotherapy Responsiveness Is Multifactorial and Heterogeneous

被引:7
作者
Reed, Jarred P. [1 ]
Posadas, Edwin M. [1 ]
Figlin, Robert A. [1 ]
机构
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
关键词
NIVOLUMAB; MELANOMA; CANCER;
D O I
10.1200/JCO.19.00639
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:1987 / +
页数:4
相关论文
共 20 条
[1]  
[Anonymous], 2018, J CLIN ONCOL S
[2]   Distribution of metastatic sites in renal cell carcinoma: a population-based analysis [J].
Bianchi, M. ;
Sun, M. ;
Jeldres, C. ;
Shariat, S. F. ;
Trinh, Q. -D. ;
Briganti, A. ;
Tian, Z. ;
Schmitges, J. ;
Graefen, M. ;
Perrotte, P. ;
Menon, M. ;
Montorsi, F. ;
Karakiewicz, P. I. .
ANNALS OF ONCOLOGY, 2012, 23 (04) :973-980
[3]   An Immune Atlas of Clear Cell Renal Cell Carcinoma [J].
Chevrier, Stephane ;
Levine, Jacob Harrison ;
Zanotelli, Vito Riccardo Tomaso ;
Silina, Karina ;
Schulz, Daniel ;
Bacac, Marina ;
Ries, Carola Hermine ;
Ailles, Laurie ;
Jewett, Michael Alexander Spencer ;
Moch, Holger ;
van den Broek, Maries ;
Beisel, Christian ;
Stadler, Michael Beda ;
Gedye, Craig ;
Reis, Bernhard ;
Pe'er, Dana ;
Bodenmiller, Bernd .
CELL, 2017, 169 (04) :736-749
[4]   Exceptional Response to Cabozantinib of Rapidly Evolving Brain Metastases of Renal Cell Carcinoma: A Case Report and Review of the Literature [J].
Ciccarese, Chiara ;
Iacovelli, Roberto ;
Mosillo, Claudia ;
Tortora, Giainpaolo .
CLINICAL GENITOURINARY CANCER, 2018, 16 (05) :E1069-E1071
[5]   Gut microbiome composition to predict resistance in renal cell carcinoma (RCC) patients on nivolumab [J].
Derosa, Lisa ;
Iebba, Valerio ;
Albiges, Laurence ;
Fidelle, Marine ;
Bonvalet, Melodie ;
Colomba, Emeline ;
Zitvogel, Laurence ;
Escudier, Bernard ;
Routy, Bertrand .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[6]   Inter and intra-tumor heterogeneity of PD-L1 and MET expression in metastatic renal cell carcinoma (mRCC). [J].
Derosa, Lisa ;
Le Teuff, Gwenael ;
Khordahi, Manal ;
Chanez, Brice ;
Zalcman, Emanuelle ;
Gravis, Gwenaelle ;
Negrier, Sylvie ;
Radulescu, Camelia ;
Albiges, Laurence ;
Merabet, Zahira ;
Escudier, Bernard J. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[7]   Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study [J].
Flippot, Ronan ;
Dalban, Cecile ;
Laguerre, Brigitte ;
Borchiellini, Delphine ;
Gravis, Gwenaelle ;
Negrier, Sylvie ;
Chevreau, Christine ;
Joly, Florence ;
Geoffrois, Lionnel ;
Ladoire, Sylvain ;
Mahammedi, Hakim ;
Rolland, Frederic ;
Gross-Goupil, Marine ;
Deluche, Elise ;
Priou, Frank ;
Laramas, Mathieu ;
Barthelemy, Philippe ;
Narciso, Berengere ;
Houede, Nadine ;
Culine, Stephane ;
Oudard, Stephane ;
Chenot, Marina ;
Tantot, Florence ;
Chabaud, Sylvie ;
Escudier, Bernard ;
Albiges, Laurence .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (23) :2008-+
[8]   Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing [J].
Gerlinger, Marco ;
Rowan, Andrew J. ;
Horswell, Stuart ;
Larkin, James ;
Endesfelder, David ;
Gronroos, Eva ;
Martinez, Pierre ;
Matthews, Nicholas ;
Stewart, Aengus ;
Tarpey, Patrick ;
Varela, Ignacio ;
Phillimore, Benjamin ;
Begum, Sharmin ;
McDonald, Neil Q. ;
Butler, Adam ;
Jones, David ;
Raine, Keiran ;
Latimer, Calli ;
Santos, Claudio R. ;
Nohadani, Mahrokh ;
Eklund, Aron C. ;
Spencer-Dene, Bradley ;
Clark, Graham ;
Pickering, Lisa ;
Stamp, Gordon ;
Gore, Martin ;
Szallasi, Zoltan ;
Downward, Julian ;
Futreal, P. Andrew ;
Swanton, Charles .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (10) :883-892
[9]   Tumor-Infiltrating and Peripheral Blood T-cell Immunophenotypes Predict Early Relapse in Localized Clear Cell Renal Cell Carcinoma [J].
Giraldo, Nicolas A. ;
Becht, Etienne ;
Vano, Yann ;
Petitprez, Florent ;
Lacroix, Laetitia ;
Validire, Pierre ;
Sanchez-Salas, Rafael ;
Ingels, Alexandre ;
Oudard, Stephane ;
Moatti, Audrey ;
Buttard, Benedicte ;
Bourass, Sarah ;
Germain, Claire ;
Cathelineau, Xavier ;
Fridman, Wolf H. ;
Sautes-Fridman, Catherine .
CLINICAL CANCER RESEARCH, 2017, 23 (15) :4416-4428
[10]   Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial [J].
Goldberg, Sarah B. ;
Gettinger, Scott N. ;
Mahajan, Amit ;
Chiang, Anne C. ;
Herbst, Roy S. ;
Sznol, Mario ;
Tsiouris, Apostolos John ;
Cohen, Justine ;
Vortmeyer, Alexander ;
Jilaveanu, Lucia ;
Yu, James ;
Hegde, Upendra ;
Speaker, Stephanie ;
Madura, Matthew ;
Ralabate, Amanda ;
Rivera, Angel ;
Rowen, Elin ;
Gerrish, Heather ;
Yao, Xiaopan ;
Chiang, Veronica ;
Kluger, Harriet M. .
LANCET ONCOLOGY, 2016, 17 (07) :976-983